🔎 Trials Near Me

Akèy › Gliyoblastòm › Alabama › Birmingham

Etid klinik pou Gliyoblastòm nan Birmingham, AL

9 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Ap rekriteFaz 2/3
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT03970447

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Ap rekriteFaz 2
  • University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Ap rekriteFaz 1/2
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06914128

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Ap rekriteFaz 1
  • University of Alabama at Birmingham Cancer Center, Birmingham
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • University of Alabama, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Ap rekriteFaz 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06319027

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

Study of Pembrolizumab and M032 (NSC 733972)

Ap rekriteFaz 1/2
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT05084430

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Birmingham
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Gliyoblastòm nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.